AMGN compared with ABBV: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ABBVAbbVie Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ABBVAbbVie Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

ABBV

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.5%▲+1.41%×0.40

Q2 FY26±3.5%▼−2.51%×0.71

= impliedAMGN realized, solidABBV realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

Q1 FY26

±4.0%

▲+3.14%

×0.78

Feb 4 '26±3.9%▼−3.79%×0.97

AMGNAmgen Inc

462.40▲+0.43%

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ABBVAbbVie Inc.

291.42▲+0.04%

Regular sessionNov 9 '26

Mkt cap$514.9BRevenue$17.4BQ3 FY26Revenue$61.2BFY25

Compare

Regular sessionNov 9 '26

AMGNAmgen Inc

ABBVAbbVie Inc.

462.40▲+0.43%

Price

291.42▲+0.04%

$249.0B

Mkt cap

$514.9B

Q3 FY26$10.4B

Revenue

$17.4BQ3 FY26

FY25$36.8B

Revenue

$61.2BFY25

AMGN462.40▲+0.43%vsABBV291.42▲+0.04%Regular sessionNov 9 '26